Events & Presentations

Date	Event Details
Mar 18, 2019 9:30 AM EDT	Jefferies HBV Investor Summit Listen to webcast Location: New York View Additional Information Dr. Given will participate in a fireside chat presentation with Maury Raycroft, Ph.D., Jefferies Biotech Analyst
Mar 12, 2019 4:20 PM EDT	Barclays Global Healthcare Conference 2019 Listen to webcast Location: Miami View Additional Information Bruce Given, M.D., Arrowhead’s chief operating officer, will deliver a corporate presentation.
Feb 22, 2019	APASL 2019 Supporting Materials: View Presentation 770.9 KB View Additional Information Dr. Edward Gane will deliver a poster presentation titled, “RNA interference (RNAi) in chronic hepatitis B (CHB): Data from Phase 2 study with JNJ-3989”
Feb 7, 2019 4:30 PM EST	Arrowhead Pharmaceuticals 2019 First Quarter Results Listen to webcast Supporting Materials: Prepared Remarks 165.2 KB
Dec 11, 2018 4:30 PM EST	Arrowhead 2018 Fiscal Year End Results Listen to webcast
Nov 28, 2018	30th Annual Piper Jaffray Healthcare Conference Listen to webcast Location: New York, NY View Additional Information November 28, 3:30 p.m. EST – Dr. Anzalone will participate in a fireside chat
Nov 16, 2018	China Nucleic Acids Supporting Materials: View Presentation 9.3 MB Location: Guangzhou, China View Additional Information November 16, 11:20 – Dr. Li will deliver an oral presentation titled, “TRiMTM Platform Based RNAi Therapeutics for AATD and Cardiometabolic Diseases”
Nov 15, 2018	Jefferies 2018 London Healthcare Listen to webcast Supporting Materials: View Presentation 10.5 MB Location: London View Additional Information November 15, 2:00 p.m. GMT – Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will deliver a corporate presentation
Nov 13, 2018	30th EORTC-NCI-AACR Symposium Supporting Materials: View Presentation 1.4 MB Location: Dublin View Additional Information November 13, 10:00 a.m. GMT – Dr. Given will deliver a poster presentation titled, “Targeting HIF2α with an RNAi therapeutic for the treatment of clear cell renal cell carcinoma”
Nov 12, 2018	American Heart Association Scientific Sessions 2018 Supporting Materials: AHA 2018 ARO-APOC3 Final 1.4 MB AHA 2018 ARO-ANG3 Final 5.2 MB Location: Chicago View Additional Information November 12, 10:45 a.m. CST – Rui Zhu, Ph.D., Arrowhead’s senior chemist, will deliver an oral presentation titled, “RNA Interference Mediated Apolipoprotein C3 Gene Silencing as a Therapeutic for Hypertriglyceridemia” November 12, 11:45 a.m. CST – So Wong, Ph.D., Arrowhead’s director of oncology, will deliver an oral presentation titled, “Development of an RNA Interference Therapeutic Targeting Angiopoietin-Like Protein 3 for Treatment of Hyperlipidemia”